Francesco Marampon

Pubblicazioni

Titolo Pubblicato in Anno
The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties FRONTIERS IN PHARMACOLOGY 2020
Sulodexide counteracts endothelial dysfunction induced by metabolic or non-metabolic stresses through activation of the autophagic program EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2019
Successful role of adjuvant radiotherapy in a rare case of tracheal inflammatory myofibroblastic tumor: a case report TUMORI 2019
The small molecule ephrin receptor inhibitor, GLPG1790, Reduces renewal capabilities of cancer stem cells, showing anti-tumour efficacy on preclinical glioblastoma models CANCERS 2019
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperation CANCER LETTERS 2019
NRF2 orchestrates the redox regulation induced by radiation therapy, sustaining embryonal and alveolar rhabdomyosarcoma cells radioresistance JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2019
Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 2019
Immune check-point in glioblastoma multiforme CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Hypofractionated intensity-modulated radiotherapy in locally advanced unresectable pancreatic cancer: a pilot study CURRENT PROBLEMS IN CANCER 2019
Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinoma MEDICAL ONCOLOGY 2019
Radiation effects on male fertility ANDROLOGY 2019
Pro-differentiating and radiosensitizing effects of inhibiting HDACs by PXD-101 (Belinostat) in in vitro and in vivo models of human rhabdomyosarcoma cell lines CANCER LETTERS 2019
The brain penetrating and dual TORC1/TORC2 inhibitor, RES529, elicits anti-glioma activity and enhances the therapeutic effects of anti-angiogenetic compounds in preclinical murine models CANCERS 2019
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival? CLINICAL NEUROLOGY AND NEUROSURGERY 2019
Parkinson's disease and light: the bright and the dark sides BRAIN RESEARCH BULLETIN 2019
Are we ready for a paradigm shift from high-dose conventional to moderate hypofractionated radiotherapy in intermediate-high risk prostate cancer? A systematic review of randomized controlled trials with trial sequential analysis CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 2019
Biological rationale for targeting MEK/ERK pathways in anti-cancer therapy and to potentiate tumour responses to radiation INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2019
Neurotoxic and neuroprotective role of exosomes in parkinson’s disease CURRENT PHARMACEUTICAL DESIGN 2019
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma JOURNAL OF HEMATOLOGY & ONCOLOGY 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma